CD274 and melanoma: Melanoma is generally characterized by high levels of PDL-1 expression, which correlates with poor prognosis; based on this finding, several monoclonal antibodies directed against the PD-1 axis have been developed and are used for melanoma treatment [56,57,58,59,60].